Latest Insider Transactions at Hille Vax, Inc. (HLVX)
This section provides a real-time view of insider transactions for Hille Vax, Inc. (HLVX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HilleVax, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HilleVax, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.78%
|
$84,000
$14.73 P/Share
|
|
May 21
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.77%
|
$84,000
$14.21 P/Share
|
|
May 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.77%
|
$90,000
$15.45 P/Share
|
|
May 03
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
723
-0.09%
|
$10,122
$14.15 P/Share
|
|
May 02
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.76%
|
$84,000
$14.01 P/Share
|
|
May 01
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
175
-0.02%
|
$2,450
$14.03 P/Share
|
|
Apr 05
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.75%
|
$84,000
$14.44 P/Share
|
|
Apr 04
2024
|
Frazier Life Sciences X, L.P. |
BUY
Open market or private purchase
|
Direct |
8,850
+0.1%
|
$123,900
$14.5 P/Share
|
|
Apr 04
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.75%
|
$84,000
$14.71 P/Share
|
|
Apr 03
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.74%
|
$84,000
$14.93 P/Share
|
|
Mar 28
2024
|
Sean Mc Loughlin Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,250
+50.0%
|
$20,000
$16.98 P/Share
|
|
Mar 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.74%
|
$985,326,000
$164221.0 P/Share
|
|
Mar 19
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.73%
|
$102,000
$17.42 P/Share
|
|
Mar 18
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.73%
|
$102,000
$17.66 P/Share
|
|
Mar 08
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.72%
|
$108,000
$18.66 P/Share
|
|
Mar 07
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.72%
|
$108,000
$18.37 P/Share
|
|
Mar 06
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$108,000
$18.95 P/Share
|
|
Feb 22
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$90,000
$15.05 P/Share
|
|
Feb 21
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.7%
|
$84,000
$14.92 P/Share
|
|
Feb 20
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.7%
|
$84,000
$14.88 P/Share
|
|
Feb 12
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
6,000
-0.69%
|
$90,000
$15.32 P/Share
|
|
Feb 08
2024
|
Aditya Kohli |
BUY
Grant, award, or other acquisition
|
Direct |
54,898
+5.95%
|
-
|
|
Feb 08
2024
|
Aditya Kohli |
SELL
Open market or private sale
|
Direct |
8,866
-1.08%
|
$124,124
$14.93 P/Share
|
|
Feb 08
2024
|
Shane Maltbie Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,522
+35.02%
|
-
|
|
Feb 08
2024
|
Shane Maltbie Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,576
-8.08%
|
$50,064
$14.93 P/Share
|
|
Feb 08
2024
|
Robert Hershberg |
BUY
Grant, award, or other acquisition
|
Direct |
174,202
+13.38%
|
-
|
|
Feb 08
2024
|
Robert Hershberg |
SELL
Open market or private sale
|
Direct |
11,597
-1.2%
|
$162,358
$14.93 P/Share
|
|
Feb 08
2024
|
Astrid Borkowski Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,632
+19.97%
|
-
|
|
Feb 08
2024
|
Astrid Borkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,933
-2.38%
|
$55,062
$14.93 P/Share
|
|
Dec 15
2023
|
Astrid Borkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.71%
|
$150,000
$15.5 P/Share
|
|
Dec 04
2023
|
Astrid Borkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.4%
|
$140,000
$14.5 P/Share
|
|
Dec 01
2023
|
Astrid Borkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.12%
|
$140,000
$14.2 P/Share
|
|
Nov 17
2023
|
Astrid Borkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.87%
|
$140,000
$14.0 P/Share
|
|
Nov 08
2023
|
Astrid Borkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.38%
|
$65,000
$13.0 P/Share
|
|
Jun 21
2023
|
Astrid Borkowski Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-4.54%
|
$160,000
$16.11 P/Share
|
|
Feb 01
2023
|
Aditya Kohli |
BUY
Grant, award, or other acquisition
|
Direct |
85,466
+9.42%
|
-
|
|
Feb 01
2023
|
Astrid Borkowski Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,333
+18.93%
|
-
|
|
Feb 01
2023
|
Shane Maltbie Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,333
+49.49%
|
-
|
|
Feb 01
2023
|
Robert Hershberg |
BUY
Grant, award, or other acquisition
|
Direct |
187,966
+16.3%
|
-
|
|
Nov 30
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
5,883,500
+46.67%
|
-
|
|
May 03
2022
|
Frazier Life Sciences X, L.P. |
BUY
Open market or private purchase
|
Direct |
1,764,706
+17.13%
|
$30,000,002
$17.0 P/Share
|
|
May 03
2022
|
Frazier Life Sciences X, L.P. |
BUY
Conversion of derivative security
|
Direct |
2,736,234
+28.78%
|
$35,571,042
$13.6 P/Share
|